GAMMA Investing’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$714K Buy
12,227
+1,202
+11% +$67K 0.02% 546
2026
Q2
$600K Buy
11,025
+1,443
+15% +$70.3K 0.02% 574
2026
Q1
$411K Buy
9,582
+443
+5% +$19K 0.02% 671
2025
Q4
$401K Buy
9,139
+1,710
+23% +$70.7K 0.02% 619
2025
Q3
$307K Sell
7,429
-917
-11% -$36.9K 0.02% 704
2025
Q2
$368K Buy
8,346
+2,889
+53% +$115K 0.02% 583
2025
Q1
$201K Buy
5,457
+1,328
+32% +$47.3K 0.02% 763
2024
Q4
$137K Buy
4,129
+1,119
+37% +$36.3K 0.01% 902
2024
Q3
$78.1K Buy
3,010
+1,004
+50% +$25K 0.01% 1171
2024
Q2
$45.1K Buy
2,006
+1,041
+108% +$23.1K 0.01% 1272
2024
Q1
$22.9K Sell
965
-175
-15% -$3.89K ﹤0.01% 1551
2023
Q4
$24.8K Buy
+1,140
New +$24.8K 0.01% 1349

Other funds holding EXEL

GAMMA Investing's EXEL Position: Q3 2026 in Review

GAMMA Investing increased its Exelixis (EXEL) stake by 11% in Q3 2026, buying an estimated $67K and bringing the position to 12,227 shares worth $714K. The position accounts for 0.02% of the portfolio, ranked #546.

GAMMA Investing first reported a position in EXEL in Q4 2023 and has held it in 12 quarters since. 26 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • GAMMA Investing held 12,227 shares of Exelixis worth $714K as of Q3 2026.
  • GAMMA Investing bought 1,202 Exelixis shares in Q3 2026, an estimated $67K.
  • Exelixis made up 0.02% of GAMMA Investing's portfolio in Q3 2026, its #546 holding.
  • GAMMA Investing first reported a position in Exelixis in Q4 2023 and has held it in 12 quarters since.
  • 26 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.